Patent · US Active

Flow promoting ocular implant

US9763829B2 · kind B2 · utility

1Cited by

164References

12Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Luke W. Clauson · Reno, US
Steven John · Menlo Park, US
David Lari · Menlo Park, US
Sean Ianchulev · Menlo Park, US
Michael Schaller · Louisville, US

Key dates

Filing date	Nov 12, 2013
Grant date	Sep 19, 2017
Priority date	—
Expiry date	Nov 21, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61F9/00781
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

Disclosed are devices, methods and systems for treatment of eye disease, including open angle glaucoma and narrow angle glaucoma. Implants are described herein that create a directed flow field, such as between the anterior chamber and either the supraciliary space or suprachoroidal space. In addition, the implant can include a variety of features, including extruded features, such as rings and pegs, which can assist in preventing ocular tissue from collapsing onto the implant and occluding fluid pathways.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.